Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Clinical trial NCT06013423 · RECRUITING

Trial details

NCT number: NCT06013423
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Leukemia of Ambiguous Lineage Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Blastic Plasmacytoid Dendritic Cell Neoplasm Hematopoietic and Lymphatic System Neoplasm Mixed Phenotype Acute Leukemia Myelodysplastic Syndrome Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Chronic Myeloid Leukemia, BCR-ABL1 Positive

Start date: 2024-07-23
Primary completion: 2031-10-31
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.